HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Roger, P. Articles by Brink, C. Search for Related Content PubMed PubMed Citation Articles by Roger, P. Articles by Brink, C.

EGTA treatment of human airways in vitro unmasks M1/MUC5AC mucin in submucosal glands

¹ Laboratoire de Pharmacologie Pulmonaire and ³ Laboratoire d'Anatomo-pathologie, Hôpital Marie Lannelongue, Le Plessis Robinson, France and ² INSERM U 482, Hôpital Saint Antoine, Paris, France

CORRESPONDENCE: C. Brink, CNRS-ESA 8078, Laboratory of Pulmonary Pharmacology, Hôpital Marie Lannelongue, 133 Av de la Résistance, 92350, Le Plessis Robinson, France. Fax: 33 0146301208

Keywords: EGTA, glands, goblet cells, human airways, M1/MUC5AC mucin

Received: December 20, 2000
Accepted March 28, 2001

Mucin staining can be used to evaluate secretory activity of human airways. However, mucin epitopes may be masked by physicochemical properties of the secretions. The aim of this investigation was to examine the effects of the calcium chelator, ethyleneglycol-bis-(ß-aminoethylether)-N, N, N', N'-tetraacetic acid (EGTA) on the detection of M1/MUC5AC mucin in isolated human bronchial preparations.

Immunohistochemical investigation and immunoradiometric assays with anti-M1 monoclonal antibodies (Mabs) were used to detect M1/MUC5AC mucin derived from bronchial preparations with an intact surface epithelium, or in tissues where the epithelium had been removed (rubbed preparations).

The Mabs labelled both epithelial goblet cells and submucosal glandular cells in EGTA (4 mM)-exposed bronchial preparations, while only goblet cells were stained in EGTA (0.4 mM)-exposed tissues. The quantities of M1/MUC5AC mucin detected in either the bronchial fluids derived from EGTA (4 mM)-exposed intact and rubbed preparations or in bronchial fluids treated with EGTA (4 mM) were significantly increased by two-fold when compared with untreated control values (p<0.001). In addition, lactate dehydrogenase (LDH) activity and protein measurements were unaltered during exposure of human airways to EGTA (4 mM) suggesting that this treatment did not affect tissue viability.

These results provide evidence that ethyleneglycol-bis-(ß-aminoethylether)-N, N, N', N'-tetraacetic acid (4 mM) facilitates the detection of M1/MUC5AC mucin by altering the physicochemical properties of respiratory mucin, thereby exposing epitopes with which anti-M1 monoclonal antibodies are reactive. This will allow more accurate measurement of secretory activity in human airways in vitro.

This article has been cited by other articles:

				E.C.I. Veerman, P.A.M. van den Keijbus, K. Nazmi, W. Vos, J.E. van der Wal, E. Bloemena, J.G.M. Bolscher, and A.V. N. Amerongen Distinct localization of MUC5B glycoforms in the human salivary glands Glycobiology, May 1, 2003; 13(5): 363 - 366. [Abstract] [Full Text] [PDF]